Stock ADVIKLA MPS PHARMAA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials MPS Pharmaa Limited

Equities

ADVIKLA

INE537C01019

Market Closed - Bombay S.E.
Other stock markets
 06:00:56 2024-05-21 am EDT 		5-day change 1st Jan Change
3.33 INR 0.00% Intraday chart for MPS Pharmaa Limited 0.00% +19.35%
Feb. 13 MPS Pharmaa Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
2023 MPS Pharmaa Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 80.27 36.31 6.88 14.33 26.56 40.13
Enterprise Value (EV) 1 146.6 98.71 69.61 70.99 84.5 107.7
P/E ratio -9.27 x -2.91 x -0.59 x -0.32 x -18.8 x -3.82 x
Yield - - - - - -
Capitalization / Revenue 1.93 x 4.32 x 57.6 x 86.1 x 82.1 x 172 x
EV / Revenue 3.53 x 11.7 x 582 x 427 x 261 x 462 x
EV / EBITDA -31.1 x -14 x -10.5 x -1.73 x -12.6 x -11.7 x
EV / FCF 1,176 x 11.1 x -182 x 11.6 x -10.8 x -18.2 x
FCF Yield 0.09% 9.03% -0.55% 8.65% -9.29% -5.5%
Price to Book 0.75 x 0.38 x 0.08 x 0.36 x 0.69 x 1.44 x
Nbr of stocks (in thousands) 19,111 19,111 19,111 19,111 19,111 19,111
Reference price 2 4.200 1.900 0.3600 0.7500 1.390 2.100
Announcement Date 9/6/18 9/1/19 11/30/20 9/2/21 9/6/22 9/5/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 41.49 8.402 0.1195 0.1664 0.3238 0.233
EBITDA 1 -4.709 -7.067 -6.629 -41.13 -6.732 -9.241
EBIT 1 -10.59 -12.95 -12.35 -46.7 -11.87 -10.7
Operating Margin -25.53% -154.08% -10,334.36% -28,059.26% -3,665.85% -4,591.68%
Earnings before Tax (EBT) 1 -10.57 -12.93 -12.36 -44.94 -9.325 -10.71
Net income 1 -8.655 -12.46 -11.67 -44.17 -1.416 -10.5
Net margin -20.86% -148.3% -9,760.57% -26,537.86% -437.31% -4,508.1%
EPS 2 -0.4529 -0.6520 -0.6106 -2.311 -0.0741 -0.5500
Free Cash Flow 1 0.1246 8.915 -0.3833 6.137 -7.851 -5.919
FCF margin 0.3% 106.1% -320.63% 3,687.8% -2,425.07% -2,540.26%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 9/6/18 9/1/19 11/30/20 9/2/21 9/6/22 9/5/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 66.3 62.4 62.7 56.7 57.9 67.6
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -14.08 x -8.829 x -9.463 x -1.377 x -8.606 x -7.312 x
Free Cash Flow 1 0.12 8.91 -0.38 6.14 -7.85 -5.92
ROE (net income / shareholders' equity) -7.74% -12.3% -13% -71.7% -3.64% -31.7%
ROA (Net income/ Total Assets) -3.3% -4.41% -4.55% -21.1% -6.91% -6.57%
Assets 1 262.1 282.7 256.7 209.7 20.48 159.8
Book Value Per Share 2 5.630 4.990 4.380 2.070 2.000 1.460
Cash Flow per Share 2 0.0100 0.0100 0.0100 0.0100 0.0100 0
Capex - 2.2 - - 0.11 1.17
Capex / Sales - 26.22% - - 34.78% 503.52%
Announcement Date 9/6/18 9/1/19 11/30/20 9/2/21 9/6/22 9/5/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. ADVIKLA Stock
  4. Financials MPS Pharmaa Limited